Pharmacogenomics and NGS in Precision Medicine : A powerful combination
Precision oncology, fueled by these advancements, is revolutionizing cancer care. As NGS technology becomes faster and more affordable, it’s becoming a standard tool in diagnosing and treating cancer. This, along with continued research in pharmacogenomics, paves the way for the development of even more effective and personalized cancer treatments.
Onco-Ribosomes—The Specialized Protein Factories Fueling Cancer
Introduction: A Revolution in Understanding Ribosomes For years, ribosomes—the cellular machines that produce proteins—were thought to be identical entities, working uniformly across different types of cells. However, research has uncovered a new and fascinating complexity: specialized ribosomes, with onco-ribosomes taking center stage in cancer biology. These specialized ribosomes selectively produce proteins that aid tumor survival […]
The Powerhouse’s Secret: Why We Must Study Mitochondrial DNA
Mitochondrial DNA (mtDNA) research has historically been underexplored, primarily due to technological limitations and the genome’s unique characteristics. However, recent advancements have begun to shed light on its significance in various diseases.
An Infinity Loop: Weaving the Future of Healthcare with NGS and Genomics
Imagine a dynamic infinity loop, where four distinct entities intertwine, their progress seamlessly feeding into each other. This loop represents the future of healthcare, propelled by the powerful synergy between next-generation sequencing (NGS), precision medicine, healthcare, and genomics research. Each element plays a crucial role, and their interconnectedness fuels the advancement of personalized, effective healthcare for all.
